Companies: 10,795·Total market cap: $144.5T
Nymox Pharmaceutical Corporation

Nymox Pharmaceutical Corporation

NYMXFOTCHealthcare● Active
$0.09
+$0.00(+0.00%)
Market Cap$8508613
P/E Ratio
52W High$0.1999
52W Low$0.03
Overview

Nymox Pharmaceutical Corporation (NYMXF) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · NYMXF · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-0.08nymxf eps ttm · nymxf earnings per shareEarnings history
PE Ratio (TTM)nymxf pe ratio ttm · nymxf price to earningsPE Ratio deep dive
Revenue (TTM)0.00nymxf revenue ttm · nymxf annual revenueFull revenue history
Dividend YieldNo Dividenddoes nymxf pay dividends · nymxf dividend yieldDividend history
Shares Outstanding93.7Mnymxf shares outstanding · nymxf floatShares outstanding history
Next EarningsTBAnymxf earnings date · nymxf next earningsEarnings history

Financial Snapshot

Full Financials
FY 2024Revenue$0.00
202220232024
nymox pharmaceutical corporation revenue · nymxf revenue 2024
FY 2024Net Income-$4.5M▲ +49.21% YoY
202220232024
nymox pharmaceutical corporation net income · nymxf profit 2024
FY 2024EPS$-0.05▲ +50.26% YoY
202220232024
nymxf eps · nymox pharmaceutical corporation earnings per share 2024
TTM:Revenue: $0.00Net Income: -$7.9MEPS: $-0.08View income statement →

Stock Performance

Full History
1D+0.00%
1W-20.07%
1M+156.41%
3M+43.20%
YTD+123.88%
1Y-10.00%
5Y-94.83%

About Nymox Pharmaceutical Corporation

CEOPaul Averback
IPO DateDec 22, 1997
Employees16
CountryBS
Websitenymox.com

Nymox Pharmaceutical Corporation is a biopharmaceutical firm focused on the research and development of medications for the aging population. Operating internationally, including in Canada, the United…

what is nymox pharmaceutical corporation · nymxf stock overview · nymox pharmaceutical corporation company profile · who is nymox pharmaceutical corporation ceo · nymxf OTC · nymox pharmaceutical corporation headquarters · nymox pharmaceutical corporation business segments

About Stock Overview & Key Data

Nymox Pharmaceutical Corporation (NYMXF) is a Healthcare company in the Biotechnology industry, listed on OTC since Dec 22, 1997. As of the latest trading session, NYMXF stock price is $0.09, with a market capitalization of $8.5M. The stock has returned -10.00% over the past 12 months and +123.88% year-to-date.

In fiscal year 2024, Nymox Pharmaceutical Corporation reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Nymox Pharmaceutical Corporation (NYMXF) stock price is $0.09. The stock is traded on OTC under the ticker symbol NYMXF. The 52-week range is $0.03 – $0.20.

NYMXF stock priceNYMXF quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice